The effects of heat and chemical inactivation on the antigenicity and immunogenicity of Vibrio cholerae 1418 in rabbits were studied. V. cholerae 1418 was inactivated with heat and chemical inactivants (phenol or Formalin) alone or in combination. Enzyme-linked immunoassay systems employing whole cells of V. cholerae 1418, lipopolysaccharide, or flagella as immobilized antigens were used to measure the antibody response (immunoglobulins G and M) after parenteral immunization of rabbits with various inactivated whole-cell preparations. The "'classical" whole-cell vaccine, produced by phenol treatment, was found to be a comparatively poor immunogen. When Formalin was used instead of phenol, the antibody response to all three enzyme-linked immunosorbent assay antigens was greatly increased. Immunoglobulin G titers to intact V. cholerae cells were as much as 100-fold higher in rabbits immunized with the Formalin-inactivated preparation as compared to the classical phenol-inactivated vaccine. Furthermore, antibody produced against the Formalin-inactivated preparation was capable of recognizing antigenic determinants expressed on the cell surface of several heterologous strains of V. cholerae. These results indicate that the antigenicity and immunogenicity of V. cholerae are greatly affected by the inactivation conditions employed for vaccine production and that Formalin is much superior to phenol as an inactivant under the conditions employed in the present study.
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The action of cholera toxin, produced by Vibrio cholerae which have colonized the small bowel, is responsible for the symptomatic fluid outpouring associated with cholera (8, 13) . Both antitoxic (7, 11, 22) and antibacterial (15, 17, 30) immunities have been shown to be protective. Although the relative contributory role that antibacterial versus antitoxic immunity may play in prevention of disease in humans is unknown, results from human volunteer studies suggest that antibacterial immunity is of prime importance (15) .
The phenol-inactivated, parenterally administered whole-cell vaccine currently in use has been found to afford only short-term protection in controlled field trials (2, 17, 18) . The precise reason(s) for poor vaccine efficacy remains unknown. However, several possible explanations exist, including poor vaccine immunogenicity, evidenced by increased protection when employed with an adjuvant (2) , and the ability of a parenterally administered vaccine to evoke a protective gut immunity (8, 9) . Additionally, the phenol inactivation process employed for vaccine production may result in destruction or alteration of somatic protective antigens. Antibody to lipopolysaccharide (LPS) (13, 25, 27) and cell surface proteins (21, 24, 31) have been shown to be protective in experimental and human (3) cholera, though their stability to heat and chemical inactivants is unknown. Furthermore, the antigenicity, and perhaps immunogenicity, of bacterial LPS is believed to be dependent upon association with cell-surface proteins (28) which may be disrupted upon inactivation.
The present study was conducted in an attempt to define inactivation conditions which would produce a preparation retaining a high degree of native antigenicity. The tion consisted of 108 cells, followed by 109-and 1010-cell doses at 2-week intervals. Sera from three rabbits were collected 1 week after the final immunization and pooled (ALC-1). For immunization with vaccine, rabbits (in groups of two) were given 1010 killed cells intramuscularly at two different sites in 0.5-ml volumes. In 2 weeks, the rabbits received a second dose of 1010 cells in the same manner. Sera were collected and pooled 2 weeks after the second immunization.
Purification of LPS. LPS from stationary-phase cultures of V. cholerae 1418 grown in CB medium was prepared by phenol-water extraction (29) . Extracted LPS was subjected to two rounds of ultracentrifugation at 100,000 x g for 1 h. The final LPS pellet was suspended in PBS and lyophilized. Purity of the final product was confirmed by obtaining an absorption spectrum from 220 to 400 nm and by determination of the protein content by the method of Lowry et al. (16) . LPS purified in such a manner contained undetectable amounts of protein.
Flagella preparations. Crude flagella were prepared by a slight modification of reported methods (24) . A 20-ml portion of an overnight culture of V. cholerae CA 401 was used to inoculate 1 liter of brain heart infusion medium in a 10-liter carboy. The cultures (5 liters) were gently shaken at 37°C until the absorbance at 540 nm (brain heart infusion blank) reached 0.3. The cells were collected by centrifugation at 6,000 x g for 10 min at 4°C. Flagella were obtained as previously described (24) ELISA. An ELISA, employing intact NaN3-killed vibrios as immobilized antigens to study cell surface antigens (CSA; CSA-ELISA), was performed essentially as described elsewhere (6) . Briefly, polystyrene tubes (13 by 100 mm) were coated with 108 washed, NaN3-killed, late log-phase cells in 1 ml of PBS-0.02% NaN3 buffer by incubation at 37°C for 3 h. Polystyrene tubes were coated with 10 ,ug of flagellar protein in 1 ml of 0.1 M sodium carbonate buffer (pH 9.2) by incubation at 37°C for 3 h. Polystyrene tubes were also coated with 50 p.g of V. cholerae 1418 LPS (12) in 1 ml of 5 mM sodium phosphate buffer (pH 7.4) by incubation at 37°C for 3 h. All coated tubes were stored at 4°C until used (usually within 2 weeks).
ELISA was performed as follows: coated tubes were washed three times with PBS containing 0.02% Tween 20 (PBS-T). Serum dilutions (1 ml in PBS-T) were added, and the tubes were incubated for 6 h at room temperature. Tubes were again washed with PBS-T. For measurement of immunoglobulin G (IgG), 1 ml of a horseradish peroxidase-Staphylococcus protein A complex prepared by the method of Nakane (20) was added. For quantitation of IgM, 1 ml of a peroxidase-labeled goat anti-rabbit IgM (Biogenzia Lemania, Lausanne, Switzerland) diluted 1:500 in PBS-T was used. Both mixtures were incubated overnight at 4°C. After three washes with PBS-T, 1 
RESULTS
The CSA-ELISA was selected as an initial screening method to monitor IgG antibody production in response to parenteral immunization with various inactivated preparations because this assay can detect antibodies against both LPS and non-LPS CSAs. Furthermore, by using Fig. 1 and Table 2 ). Antiserum ALC-1, produced in response to repeated injections of live vibrios, was used as a reference serum. Representative titration curves of serum samples obtained from both experiments in the CSA, LPS, and flagella ELISAs are shown in Fig. 1 . The phenol-inactivated preparation elicited antibody titers substantially lower than those of the Formalin-inactivated preparation in all three assay systems in both experiments. Although the configuration of the curves varied depending upon both the assay system and experiment, the trend was constant. The CSA, flagella, and LPS IgG antibody titers for both experiments are shown in Table 2 . The greatest difference in titer was seen in the CSA-ELISA, in which the Formalin-inactivated preparation evoked titers approximately 100-fold higher than those of the phenol-inactivated preparation in both experiments. Marked differences in titer were also observed in the LPS and flagella ELISAs. The anti-LPS titer was from 15-fold (experiment 1) to 55-fold (experiment 2) higher when the Formalin-inactivated preparation was used as an immunogen. A similar trend was also seen in anti-flagella titers (Table 2) . ALC-1 possessed the highest titer in all three assays, although the difference, as compared to the response elicited against the Formalin-inactivated preparation, was less than twofold in the LPS and flagella ELISAs and approximately two-to sevenfold less in the CSA-ELISA.
The IgM antibodies present in antisera raised against the phenol-and Formalin-inactivated preparations were also determined in the three ELISA systems (data not shown). Although the differences in IgM titers were not of the same magnitude as seen with the IgG titers, the trend was the same.
Next, the antisera raised against phenol-and Formalin-inactivated V. cholerae 1418 (inactivation procedures 1 and 3, respectively, from Table 1 ) were tested for reactivity against several strains of V. cholerae representing various combinations of serotype and biotype (Table 3) . Again, as when the homologous strain was used as an immobilized antigen, the antisera produced in response to the Formalin-inactivated preparation possessed titers at least 60-fold higher than those evoked by the phenol-inactivated preparation for all strains tested.
DISCUSSION
There can be little doubt that antibacterial immunity contributes significantly to protection against cholera in humans (2, 5, 15, 17, 30). However, relatively little is known about the protective somatic antigens of V. cholerae, especially relating to their expression by viable cells (14) and their susceptibility to alteration or destruction by heat or chemical means of inactivation used for vaccine production. Recently, several protective somatic antigens have been identified, including LPS and flagella (21, 24, 27, 31) .
Results from controlled field trials employing phenol-inactivated whole-cell vaccines have been generally disappointing. Protection was found to be limited to certain populations and to be of short duration (2, 17) . Several explanations have been put forth to explain these results, given represent the geometric mean of three independent determinations, with the standard deviation in parentheses. Sera tested were from experiment 1. including: (i) poor immunogenicity of the vaccine (2); (ii) selection of vaccine strains with low antigenicity (8) ; and (iii) suboptimal route of immunization (8, 9, 17) .
Although it is widely accepted that the currently employed phenol-inactivated whole-cell vaccine offers only marginal protection, few studies have been performed in an attempt to improve the efficacy of inactivated whole-cell vaccines (19, 26) . To date, there have been no studies aimed at comparing the effect of different inactivating procedures on the immunogenicityantigenicity of whole-cell vaccines. In the present report we have studied the immune response in rabbits to parenteral immunization with various killed whole-cell preparations of V. cholerae 1418. Since several V. cholerae somatic antigens have been implicated as protective antigens, the antibody response against two such antigens (LPS and flagella) in addition to NaN3-killed whole cells was evaluated by using sensitive and specific ELISA systems.
V. cholerae inactivated with phenol and heat was found to be a comparatively poor immunogen. Since the LPS employed as an immobilized antigen in the ELISA was purified by phenolwater extraction, phenol-induced antigenic alterations to cell-associated LPS would not be expected to account solely for the differences in titers observed. One possibility is that phenol treatment extracts a portion of the LPS from cells during the inactivation process. Such extracted LPS may possess a lower antigenic potency than cell-associated LPS. Perhaps of more importance are the alterations caused to the cell surface by the removal of LPS alone or together with associated proteins. Formalin treatment would not be expected to extract appreciable amounts of LPS, thereby limiting these types of cell surface alterations.
It is interesting that antiserum raised against the Formalin-inactivated preparation was capable of recognizing cell surface antigenic determinants possessed by heterologous strains of V. cholerae. The IgG titers against all three heterologous strains were only about twofold less than those of the reference antiserum ALC-1. Again, antiserum produced against the phenolinactivated preparation had very low titers to all three heterologous strains. It would therefore appear that the Formalin inactivation procedure conserves antigenic determinants shared by different strains of V. cholerae.
Although only one alternative chemical inactivant (Formalin) was compared with phenol for production of a whole-cell vaccine, the results obtained, as concerns the immune response to parenteral immunization, were promising. It remains to be determined whether the higher levels of antibody produced against the Formalininactivated preparation are protective and how effective the Formalin-inactivated preparation is as an oral immunogen. However, the results obtained offer at least one plausible explanation for the poor showing of previously tested phenol-inactivated vaccines. Furthermore, the use of a highly immunogenic-antigenic killed-cell preparation, perhaps in conjunction with a cholera toxoid (10, 23) , as a vaccine may prove effective for inducing both antibacterial and antitoxic immunity. 
